top of page

Downloadable Materials

Speaker Presentations

Find the presentations from the event speakers here in PDF format. Click on the orange arrows to download.

Historical Perspective of Medical Products of Human Origin (MPHO)

Dr. Luc Noël, Advisor, MPHO


PLENARY SESSION 2: Traceability Challenges

Chairs: Prof. Dr. Jeremy Chapman and Dr. Ruth Warwick

The Overarching Traceability Needs for MPHO

Dr. Axel Rahmel, German Organ Transplant Foundation (DSO)


The Challenge of Ensuring MPHO Traceability Across Multiple Professional Spheres of Activity

Dr Aurora Vassanelli, Italian National Transplant Centre (CNT)


FDA's Regulatory Framework for Ensuring Traceability of Blood and Blood Components

Dr. Wendy Paul, US Food and Drug Administration (FDA)

PLENARY SESSION 3: Implications of Unregulated Activities for Patient Safety

Chairs: Dr. Ineke Slaper-Cortenbach and Dr. Ziggy Szczepiorkowski

Overview of MPHO Patient Safety in Regulated as well as in Unregulated Environments

Prof. Dr. Jeremy Chapman, Medicine and Cancer at Westmead Hospital, Australia

Unproven Therapies and Patient Safety

Dr. Mickey Koh, WBMT Graft Processing and Cellular Therapy Committee/ISCT task force


Patient Safety, Ethics, and Approvals in CAR T Cell Therapy

Dr. Bruce Levine, President-Elect International Society for Cell and Gene Therapy (ISCT)

PLENARY SESSION 5: Celebration of the 25th Anniversary of ICCBBA: Ensuring Transparency on a Global Basis

Chairs: Mrs. Diane Wilson and Mr. Paul Ashford


One World Award Speech: Continental Unite – Past and Future Traceability of Substances of Human Origin

Ms. Suzanne Butch and Dr. Jørgen Georgsen


PLENARY SESSION 6: Scientific and Ethical Practice: Future Challenges

Chairs: Prof. Dr. Martin Hildebrandt and Dr. Kelly Tilleman



What are the Current Challenges of the Ethical Use of MPHO?

Dr. José Nunez, World Health Organization - Geneva



Genetic Manipulation in Human Reproduction: What are the Challenges?

Dr. Ewa Bartnik, WHO expert advisory group on developing global standards for governance and oversight of Human genome editing



PLENARY SESSION 7: Vigilance and Surveillance of MPHO – the Notify Project and Other International Initiatives

Chairs: Prof. Timothy Pruett and Dr. Salwa Hindawi



EU Strategies for the Vigilance and Surveillance of Substances of Human Origin

Dr. Deirdre Fehily, Directorate-General for Health and Food Safety, European Commission (DG SANTE)

Monitoring the Occurrence of Adverse Events Associated with the Use of Medical Products of Human Origin in the U.S.

Dr. Jefferson Jones, US Centers for Disease Control and Prevention (CDC)


How the NOTIFY Project can Improve the Safety of Transfusion/Transplantation/Application of MPHO.

Dr. Aurora Navarro Cantullera, The Catalan Transplant Organization (OCATT)

PLENARY SESSION 9: Healthcare Informatics and the Role of New Technologies

Chairs: Prof. Dr. Martin Hildebrandt and Dr. Jørgen Georgsen

Cloud, Block Chain and Related Technologies: MPHO Impacts and Opportunities

Mr. Wayne Bolton, Australian Red Cross Blood Service and chair of ICCBBA, TAG-Information Technology Committee


Ethical Aspects of Artificial Intelligence in Medicine

Dr. Stuart McLennan, Technical University Munich, Germany

Event Photography

Photography from Forum 25 is now available in the gallery below. Click on the thumbnails to view photos and to download the photos, click on the orange arrows.

Day 1 - Sep 18th 2019
Day 2 - Sep 19th 2019
Day 3 - Sep 20th 2019
Event Photos
bottom of page